PNC Financial Services Group
ALXO icon

PNC Financial Services Group’s ALX Oncology ALXO Stock Holding History

PNC Financial Services Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207 Hold
100
– – ﹤0.01% 5100
2026
Q1 		$201 Hold
100
– – ﹤0.01% 5033
2025
Q4 		$113 Hold
100
– – ﹤0.01% 5044
2025
Q3 		$183 Sell
100
-297
-75% -$257 ﹤0.01% 4949
2025
Q2 		$165 Sell
397
-450
-53% -$227 ﹤0.01% 4811
2025
Q1 		$528 Buy
847
+530
+167% +$636 ﹤0.01% 4636
2024
Q4 		$529 Buy
317
+186
+142% +$286 ﹤0.01% 4519
2024
Q3 		$238 Hold
131
– – ﹤0.01% 4664
2024
Q2 		$790 Hold
131
– – ﹤0.01% 4473
2024
Q1 		$1.46K Hold
131
– – ﹤0.01% 4278
2023
Q4 		$1.95K Buy
131
+31
+31% +$294 ﹤0.01% 4193
2023
Q3 		$480 Sell
100
-832
-89% -$4.51K ﹤0.01% 4465
2023
Q2 		$7K Hold
932
– – ﹤0.01% 4013
2023
Q1 		$4.21K Buy
932
+832
+832% +$6.3K ﹤0.01% 4094
2022
Q4 		$1.13K Hold
100
– – ﹤0.01% 4388
2022
Q3 		$1K Hold
100
– – ﹤0.01% 4280
2022
Q2 		$1K Hold
100
– – ﹤0.01% 4309
2022
Q1 		$2K Sell
100
-2,000
-95% -$34.1K ﹤0.01% 4166
2021
Q4 		$45K Buy
2,100
+2,000
+2,000% +$86.3K ﹤0.01% 3161
2021
Q3 		$7K Buy
+100
New +$6.67K ﹤0.01% 3832

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

PNC Financial Services Group's ALXO Position: Q2 2026 in Review

PNC Financial Services Group held its ALX Oncology (ALXO) position steady in Q2 2026 at 100 shares worth $207. The position accounts for ﹤0.01% of the portfolio, ranked #5100.

PNC Financial Services Group first reported a position in ALXO in Q3 2021 and has held it in 20 quarters since. The position peaked at $45K in Q4 2021. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • PNC Financial Services Group held 100 shares of ALX Oncology worth $207 as of Q2 2026.
  • PNC Financial Services Group left its ALX Oncology share count unchanged in Q2 2026.
  • ALX Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5100 holding.
  • PNC Financial Services Group first reported a position in ALX Oncology in Q3 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's ALX Oncology position peaked at $45K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.